Trabec 1mg Infusion

Trabec 1mg Infusion contains Trabectedin, an antineoplastic agent belonging to the alkylating agents class. It is indicated for treatment of liposarcoma (cancer arising in fat cells) or leiomyosarcoma (cancer arising in smooth muscle tissue) that has metastasised to other body sites and cannot be managed surgically in patients who have received prior anti-cancer therapy. It is also indicated for recurrent ovarian cancer following at least one previous treatment line in patients who have not responded to other therapies.

Do not take Trabec 1mg Infusion if you are allergic to Trabectedin or any other ingredient in this medicine, if you have serious infections, if you are breastfeeding, or if you will receive a yellow fever vaccine. Inform your doctor if you have an active infection, or history of infections, liver disease, kidney problems, or cardiac disease. This medicine may impair fertility; discuss with your doctor before planning pregnancy. Report to your doctor if you experience sudden difficulty in breathing, fever, skin redness or flushing, rash, nausea, or vomiting following the infusion. Trabec 1mg Infusion is not recommended in children and young people under 18 years of age. Use effective contraception during treatment. Avoid pregnancy and breastfeeding during therapy.

Liposarcoma or Leiomyosarcoma

Trabec 1MG Infusion is an alkylating agent, that causes a disruption in the tumor cell cycle and cell death by initiating a cascade of events triggered by the binding of certain nucleobases in the DNA preventing the multiplication of tumor cells. It works by slowing or stopping the growth of cancer cells in the body

It will be given to you by a doctor or nurse in a hospital or clinic setting trained in cancer chemotherapy. It is given as an intravenous infusion drip (into your vein). Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity, body weight, and other factors. Your doctor will give you certain medications to lessen the chance of getting side effects from the Trabec 1MG Infusion treatment.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Constipation Decrease in appetite Diarrhea Nausea, vomiting Anemia Decreased albumin levels Decreased platelet count Headache Shortness of breath Tiredness Serious Heart problems Skin rashes Liver problems Severe muscle pain

Trabec 1MG Infusion may interfere with vaccines, inform your physician before taking yellow fever vaccine or any other vaccines. This injection may cause severe birth defects if taken during pregnancy. Female patients with reproductive potential should use effective contraception during the treatment. Male patients with female partners with reproductive potential should use effective birth control methods during the treatment and for at least 5 months after their last dose. Do not breastfeed during treatment with this injection. Your doctor may advise you to take certain tests to check for the effectiveness of the therapy.